Quốc gia: Israel
Ngôn ngữ: Tiếng Anh
Nguồn: Ministry of Health
DABIGATRAN ETEXILATE AS MESYLATE
TEVA ISRAEL LTD
B01AE07
CAPSULES
DABIGATRAN ETEXILATE AS MESYLATE 110 MG
PER OS
Required
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
DABIGATRAN ETEXILATE
Primary prevention of venous thromboembolic events in adult patients who have undergone elective total hip replacement surgery or total knee replacement surgery.Prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation.Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults
2020-11-01
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986 The medicine is dispensed with a doctor’s prescription only DABIGATRAN TEVA 110 MG CAPSULES THE ACTIVE INGREDIENT: Each capsule of DABIGATRAN TEVA 110 MG contains: 110 mg dabigatran etexilate (as mesylate) For information about inactive ingredients see section 6 – “Additional information”. READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have additional questions, refer to the doctor or the pharmacist. This medicine has been prescribed for treatment of your illness. Do not pass it on to others. It may harm them even if it seems to you that their illness is similar. Patient information card: This card contains important safety information, which you need to know before starting treatment with Dabigatran Teva and during the treatment with Dabigatran Teva. The card contains information intended for both the patient and the healthcare staff. It provides guidance for patients on how to minimize the risk of bleeding, which results from treatment with any of the anticoagulant preparations. In addition, the card contains personal details of the patient and information regarding the medicine Dabigatran Teva for the healthcare staff. Present this card to any healthcare professional involved in your treatment. 1. WHAT IS THE MEDICINE INTENDED FOR? Dabigatran Teva contains the active ingredient dabigatran etexilate, which belongs to a group of medicines called “anticoagulants”. Dabigatran Teva is intended for adults: 1. For primary prevention of thrombosis of the veins following elective orthopedic surgeries of total knee replacement or total hip replacement. 2. For the prevention of stroke and systemic embolism in adult patients suffering from irregular heartbeat (atrial fibrillation) that is unrelated to valve disease. 3. For the treatment of blood clots in the leg veins (deep vein thrombosis (DVT)) and in the pulmonary blood vessels (pulmonar Đọc toàn bộ tài liệu